Cargando…
Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H
The coxsackievirus B3 strain PD-0 has been proposed as a new oncolytic virus for the treatment of colorectal carcinoma. Here, we generated a cDNA clone of PD-0 and analyzed the virus PD-H, newly generated from this cDNA, in xenografted and syngenic models of colorectal cancer. Replication and cytoto...
Autores principales: | Hazini, Ahmet, Dieringer, Babette, Klingel, Karin, Pryshliak, Markian, Geisler, Anja, Kobelt, Dennis, Daberkow, Ole, Kurreck, Jens, van Linthout, Sophie, Fechner, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539752/ https://www.ncbi.nlm.nih.gov/pubmed/34696348 http://dx.doi.org/10.3390/v13101918 |
Ejemplares similares
-
Coxsackievirus B3—Its Potential as an Oncolytic Virus
por: Geisler, Anja, et al.
Publicado: (2021) -
Silencing of Mcl-1 overcomes resistance of melanoma cells against TRAIL-armed oncolytic adenovirus by enhancement of apoptosis
por: Tolksdorf, Beatrice, et al.
Publicado: (2021) -
Lipid nanoparticle-encapsulated, chemically modified anti-adenoviral siRNAs inhibit hepatic adenovirus infection in immunosuppressed Syrian hamsters
por: Geisler, Anja, et al.
Publicado: (2023) -
Tackling HLA Deficiencies Head on with Oncolytic Viruses
por: Fisher, Kerry, et al.
Publicado: (2021) -
Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections
por: Fechner, Henry, et al.
Publicado: (2011)